Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Future Microbiol. 2008;3(6):649-660.

Novel CDSCO and US FDA approved pneumonia drugs to ease public health challenge: Nandita Vijayasimha., Bengaluru Friday, December 13, 2024, 08:00 Hrs [IST] Indian healthcare provi ...

Their analysis shows that children's risk of developing asthma ... Combination Treatment Improves Response to Immunotherapy for Lung Cancer Sep. 25, 2024 — Researchers have tested a combination ...

Dec. 11, 2024 — Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID-19 and Ebola -- while also minimizing side effects ...

When bacteria enter the bloodstream (bacteremia), they can cause severe infection leading to sepsis (the body's extreme ...

Across India, at least 30 critically ill patients infected with multidrug-resistant (MDR) or extreme drug-resistant (XDR) bacteria that don’t respond to even last-line antibiotics — also called superb ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...